The estimated prevalence of homocystinuria in the United States is 1 in 100,000 to 200,000, but the actual prevalence may be much higher, due to the inaccuracy of the screening test
It was included as a tertiary agent in the 2017 edition of the multi-agency clinical guidelines for the treatment of hypertension (Whelton et al, 2018), but was no longer mentioned in the 2025 AHA/ACC multisociety hypertension guidelines (Jones et al, 2025)
Oltre a UniCamillus e Vanvitelli, nello studio sono stati coinvolti anche ricercatori dellUniversit di Salerno e dellINRCA-IRCCS di Ancona Il Prof
Switching Between GLP-1 Agonists: Does the Interaction Profile Change
Given their infrastructure for medical supervision, therapy, and long-term care, these center can offer controlled pilot programs to test efficacy on small patient groups
For frequent travellers or those without reliable refrigeration, this presents a significant challenge